Results 101 to 110 of about 491,575 (216)

Hyperthermic Intraperitoneal Chemotherapy [PDF]

, 2020
openaire   +2 more sources

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer

, 2019
The management of peritoneal metastases from gastric cancer origin has evolved considerably over the last three decades with the establishment of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) as efficacious therapies ...
Adriana C. Gamboa, Joshua H. Winer
core   +1 more source

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case series

Asian Journal of Medical Sciences
Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment for advanced abdominopelvic malignancies with peritoneal carcinomatosis. Cytoreductive surgery (CRS) with HIPEC offers hope by increasing the survival rates of these cancers ...
Aswini Lakshminarasimhan , Rajasekar Radhakrishnan , Gowtham Selvarasu   +2 more
doaj   +1 more source

Data for: Systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade mucinous carcinoma peritonei of appendiceal origin

, 2019
The use of systemic chemotherapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in appendiceal carcinomatosis is not associated with better clinical outcomes.
Sardi, Armando, sardi, A (via Mendeley Data)   +1 more
core   +1 more source

Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results

, 2015
Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC.
ROVIELLO, FRANCO, ROVIELLO, GIANDOMENICO, MARRELLI, DANIELE, PETRIOLI, ROBERTO   +3 more
core   +1 more source

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study

Pleura and Peritoneum
This explorative porcine study investigated the immediate postoperative response of inflammatory protein markers and ischemic metabolites in peritoneal abdominal wall tissue during and after hyperthermic intraperitoneal chemotherapy (HIPEC) assessed by ...
Petersen Elisabeth Krogsgaard, Bue Mats, Harlev Christina, Jørgensen Andrea René, Hanberg Pelle, Petersen Lone Kjeld, Stilling Maiken   +6 more
doaj   +1 more source

Factors influencing hematological toxicity and adverse effects of perioperative hyperthermic intraperitoneal vs intraperitoneal chemotherapy in gastrointestinal cancer

Open Medicine
Intraperitoneal (IP) chemotherapy (IPC), including hyperthermic intraperitoneal chemotherapy (HIPEC), has emerged as a promising approach to control peritoneal metastases in gastrointestinal (GI) cancers. However, the safety profile and toxicity spectrum
Zhang Xue, Zheng Zhewen, Gao Hui, Yang Ziqi, Bai Jian   +4 more
doaj   +1 more source

Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.

, 2010
BACKGROUND: Survival benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion was demonstrated by a prospective randomized trial for colorectal peritoneal carcinomatosis.
Ibrahim, Zuhaib, MD, Bartlett, David L, Gusani, Niraj J, Holtzman, Matthew P, Franko, Jan, Zeh, Herbert J   +5 more
core  

Time course of cytokines, hemodynamic and metabolic parameters during hyperthermic intraperitoneal chemotherapy

, 2016
Systemic response to cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) causes the activation of endocrine, metabolic, hemodynamic and inflammatory processes.
Finazzi, Paolo, Bianchetti, Andrea, Catena, Fausto, Ceresoli, Marco, Lorini, Luca F, Ansaloni, Luca, Prussiani, Viviana, Sonzogni, Valter, Coccolini, Federico, Benigni, Alberto, Bertoli, Paolo, Corbella, Davide, Manfredi, Roberto, Poiasina, Elia, Brambillasca, Pietro, Bontempelli, Mario   +15 more
core  

Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC

Pleura and Peritoneum
To evaluate the implementation, compliance, and impact of the enhanced recovery after surgery (ERAS) protocol on perioperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for Stage ...
Somashekhar S. P., Rohit Kumar C., Fernandes Aaron, Ahuja Vijay, Aggarwal Kushal, Shanbhag Esha, Ashwin K. R.   +6 more
doaj   +1 more source